Vitamin D nutritional status and bone turnover markers in childhood acute lymphoblastic leukemia survivors: A PETALE study

Delvin, E.; Alos, N.; Rauch, F.; Marcil, V.; Morel, S.; Boisvert, M.; Lecours, M.-A.; Laverdière, C.; Sinnett, D.; Krajinovic, M.; Dubois, J.; Drouin, S.; Lefebvre, G.; Samoilenko, M.; Nyalendo, C.; Cavalier, Etienne; Levy, Etienne

doi:10.1016/j.clnu.2018.02.006

Article (Scientific journals)

Vitamin D nutritional status and bone turnover markers in childhood acute lymphoblastic leukemia survivors: A PETALE study

Delvin, E.; Alos, N.; Rauch, F. et al.

2019 • In Clinical Nutrition

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/228406

DOI
10.1016/j.clnu.2018.02.006

PubMed
29503055

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Vitamin D ALL survivors 2018.pdf

Publisher postprint (618.86 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Acute lymphoblastic leukemia; Bone formation; Bone resorption; CTX; P1NP

Abstract :

[en] Background: The remarkable progress in the treatment of childhood acute lymphoblastic leukemia (cALL) has led to a survival rate reaching 90%. This success story is unfortunately linked to increased risk of impaired skeletal mass accumulation during childhood and adolescence, predisposing the patients to osteoporosis and pathological fractures at adulthood. Objective: This study aims at characterizing the vitamin D status and bone health biomarkers in a well-characterized cohort of cALL survivors. Results: Food frequency questionnaires reveal that (i) the total vitamin D intake varies greatly (44–2132 IU/d), (ii) only 16.8% of the participants consume vitamin D supplements, and (iii) 74% of survivors' intakes are below the Recommended Daily Intakes (400 IU/d). For the 42 participants taking vitamin D supplements, the median (2.5–97.5%iles) intake is 600 IU/d (21.2–1972 IU/d). Sixteen participants are vitamin D deficient (<30 nM) and 66 insufficient (≥30 – <50 nM). Serum 24,25(OH)2D3 concentrations are directly related to those of 25OHD3, and those of 3-epi-25OHD3 below the Lower Limit of Quantification in most samples. The participants' serum concentrations of cross-linked C-telopeptide of type-I collagen and intact amino-terminal pro-peptide of type-I collagen decrease steadily with age, leveling at adulthood, and are at all times higher in males. Conclusion: The present study shows that the prevalence of vitamin D insufficiency or deficiency is not greater in cALL survivors compared to the general Canadian population despite low vitamin D food and supplement intakes. Furthermore, there seem to be no overt imbalance in the gender- and age-adjusted serum bone turnover marker concentrations. © 2018 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism

Disciplines :

Laboratory medicine & medical technology
Pediatrics

Author, co-author :

Delvin, E.; Sainte-Justine UHC Research Centre, Canada, Department of Biochemistry and Molecular Medicine, Université de Montréal, Canada

Alos, N.; Sainte-Justine UHC Research Centre, Canada, Department of Pediatrics, Université de Montréal, Canada

Rauch, F.; Shriners Hospital for Children, Canada, McGill University Health Centre Research Institute, McGill University, Montreal, Canada

Marcil, V.; Sainte-Justine UHC Research Centre, Canada, Department of Nutrition, Université de Montréal, Canada

Morel, S.; Sainte-Justine UHC Research Centre, Canada

Boisvert, M.; Sainte-Justine UHC Research Centre, Canada

Lecours, M.-A.; Sainte-Justine UHC Research Centre, Canada

Laverdière, C.; Sainte-Justine UHC Research Centre, Canada, Department of Pediatrics, Université de Montréal, Canada

Sinnett, D.; Sainte-Justine UHC Research Centre, Canada, Department of Pediatrics, Université de Montréal, Canada

Krajinovic, M.; Sainte-Justine UHC Research Centre, Canada, Department of Pediatrics, Université de Montréal, Canada

More authors (7 more)

Language :

English

Title :

Vitamin D nutritional status and bone turnover markers in childhood acute lymphoblastic leukemia survivors: A PETALE study

Publication date :

2019

Journal title :

Clinical Nutrition

ISSN :

0261-5614

eISSN :

1532-1983

Publisher :

Churchill Livingstone

Peer reviewed :

Peer Reviewed verified by ORBi

Funders :

CIHR - Canadian Institutes of Health Research

Available on ORBi :

since 08 October 2018

Statistics

Number of views

78 (9 by ULiège)

Number of downloads

5 (4 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Riedt, T., Ebinger, M., Salih, H.R., Tomiuk, J., Handgretinger, R., Kanz, L., et al. Aberrant expression of the homeobox gene CDX2 in pediatric acute lymphoblastic leukemia. Blood 113:17 (2009), 4049–4051.
Viana, S.S., de Lima, L.M., do Nascimento, J.B., Cardoso, C.A., Rosário, A.C., deQ. Mendonça, C., et al. Secular trends and predictors of mortality in acute lymphoblastic leukemia for children of low socioeconomic level in Northeast Brazil. Leuk Res 39:10 (2015), 1060–1065.
Hunger, S.P., Lu, X., Devidas, M., Camitta, B.M., Gaynon, P.S., Winick, N.J., et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. J Clin Oncol Offic J Am Soc Clin Oncol 30:14 (2012), 1663–1669.
Zhang, F.F., Parsons, S.K., Obesity in childhood cancer survivors: call for early weight management. Adv Nutr (Bethesda, Md) 6:5 (2015), 611–619.
Chow, E.J., Simmons, J.H., Roth, C.L., Baker, K.S., Hoffmeister, P.A., Sanders, J.E., et al. Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation. Biol Blood Marrow Transplant 16:12 (2010), 1674–1681.
Barnea, D., Raghunathan, N., Friedman, D.N., Tonorezos, E.S., Obesity and metabolic disease after childhood cancer. Oncology (Williston Park) 29:11 (2015), 849–855.
Arikoski, P., Komulainen, J., Riikonen, P., Jurvelin, J.S., Voutilainen, R., Kroger, H., Reduced bone density at completion of chemotherapy for a malignancy. Arch Dis Child 80:2 (1999), 143–148.
Salim, H., Ariawati, K., Suryawan, W.B., Arimbawa, M., Osteoporosis resulting from acute lymphoblastic leukemia in a 7-year-old boy: a case report. J Med Case Rep, 8, 2014, 168.
Rogalsky, R.J., Black, G.B., Reed, M.H., Orthopaedic manifestations of leukemia in children. J Bone Jt Surg Am Vol 68:4 (1986), 494–501.
Halton, J.M., Atkinson, S.A., Fraher, L., Webber, C.E., Cockshott, W.P., Tam, C., et al. Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia. J Pediatr 126:4 (1995), 557–564.
Boot, A.M., van den Heuvel-Eibrink, M.M., Hählen, K., Krenning, E.P., de Muinck Keizer-Schrama, S.M.P.F., Bone mineral density in children with acute lymphoblastic leukaemia. Eur J Canc 35:12 (1999), 1693–1697.
Halton, J., Gaboury, I., Grant, R., Alos, N., Cummings, E.A., Matzinger, M., et al. Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program. J Bone Miner Res Offic J Am Soc Bone Miner Res 24:7 (2009), 1326–1334.
Alikasifoglu, A., Yetgin, S., Cetin, M., Tuncer, M., Gumruk, F., Gurgey, A., et al. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments. Am J Hematol 80:2 (2005), 113–118.
Gunes, A.M., Can, E., Saglam, H., Ilcol, Y.O., Baytan, B., Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia. J Pediatr Hematol Oncol 32:3 (2010), e102–e107.
Gurney, J.G., Kaste, S.C., Liu, W., Srivastava, D.K., Chemaitilly, W., Ness, K.K., et al. Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: results from the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer 61:7 (2014), 1270–1276.
Pagano-Therrien, J., Santacroce, S.J., Bone mineral density decrements and children diagnosed with cancer. J Pediatr Oncol Nurs Offic J Assoc Pediatr Oncol Nurses 22:6 (2005), 328–338.
Kaste, S.C., Karimova, E.J., Neel, M.D., Osteonecrosis in children after therapy for malignancy. AJR Am J Roentgenol 196:5 (2011), 1011–1018.
Prentice, A., Schoenmakers, I., Laskey, M.A., de Bono, S., Ginty, F., Goldberg, G.R., Nutrition and bone growth and development. Proc Nutr Soc 65:4 (2006), 348–360.
Berger, C., Goltzman, D., Langsetmo, L., Joseph, L., Jackson, S., Kreiger, N., et al. Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis. J Bone Miner Res Offic J Am Soc Bone Miner Res 25:9 (2010), 1948–1957.
Anderson, P.H., Atkins, G.J., Turner, A.G., Kogawa, M., Findlay, D.M., Morris, H.A., Vitamin D metabolism within bone cells: effects on bone structure and strength. Mol Cell Endocrinol 347:1–2 (2011), 42–47.
Gunton, J.E., Girgis, C.M., Baldock, P.A., Lips, P., Bone muscle interactions and vitamin D. Bone 80 (2015), 89–94.
Anderson, P.H., Lam, N.N., Turner, A.G., Davey, R.A., Kogawa, M., Atkins, G.J., et al. The pleiotropic effects of vitamin D in bone. J Steroid Biochem Mol Biol 136 (2013), 190–194.
Atkins, G.J., Kostakis, P., Pan, B., Farrugia, A., Gronthos, S., Evdokiou, A., et al. RANKL expression is related to the differentiation state of human osteoblasts. J Bone Miner Res Offic J Am Soc Bone Miner Res 18:6 (2003), 1088–1098.
Henry, H.L., Regulation of vitamin D metabolism. Best Pract Res Clin Endocrinol Metabol 25:4 (2011), 531–541.
Atkins, G.J., Anderson, P.H., Findlay, D.M., Welldon, K.J., Vincent, C., Zannettino, A.C.W., et al. Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1α,25-dihydroxyvitamin D3. Bone 40:6 (2007), 1517–1528.
Kogawa, M., Anderson, P.H., Findlay, D.M., Morris, H.A., Atkins, G.J., The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts. J Steroid Biochem Mol Biol 121:1–2 (2010), 277–280.
Need, A.G., Horowitz, M., Morris, H.A., Nordin, B.C., Vitamin D status: effects on parathyroid hormone and 1, 25-dihydroxyvitamin D in postmenopausal women. Am J Clin Nutr 71:6 (2000), 1577–1581.
Haarburger, D., Hoffman, M., Erasmus, R.T., Pillay, T.S., Relationship between vitamin D, calcium and parathyroid hormone in Cape Town. J Clin Pathol 62:6 (2009), 567–569.
Fillee, C., Keller, T., Mourad, M., Brinkmann, T., Ketelslegers, J.M., Impact of vitamin D-related serum PTH reference values on the diagnosis of mild primary hyperparathyroidism, using bivariate calcium/PTH reference regions. Clin Endocrinol 76:6 (2012), 785–789.
Gedikoglu, G., Altinoz, M.A., Differentiation-inducing liposoluble vitamin deficiency may explain frequent secondary solid tumors after hematopoietic stem cell transplantation: minireview. Neoplasma 55:1 (2008), 1–9.
Stein, E.M., Shane, E., Chapter 68-vitamin D and organ transplantation A2 – Adams, David Feldman J. Wesley Pike John S. Vitamin D. 3rd ed., 2011, Academic Press, San Diego, 1291–1298.
Simmons, J.H., Chow, E.J., Koehler, E., Esbenshade, A., Smith, L.A., Sanders, J., et al. Significant 25-hydroxyvitamin D deficiency in child and adolescent survivors of acute lymphoblastic leukemia: treatment with chemotherapy compared with allogeneic stem cell transplant. Pediatr Blood Cancer 56:7 (2011), 1114–1119.
Modan-Moses, D., Pinhas-Hamiel, O., Munitz-Shenkar, D., Temam, V., Kanety, H., Toren, A., Vitamin D status in pediatric patients with a history of malignancy. Pediatr Res 72:6 (2012), 620–624.
Munns, C.F., Shaw, N., Kiely, M., Specker, B.L., Thacher, T.D., Ozono, K., et al. Global consensus recommendations on prevention and management of nutritional rickets. J Clin Endocrinol Metab 101:2 (2016), 394–415.
Krajinovic, M., Labuda, D., Richer, C., Karimi, S., Sinnett, D., Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood 93:5 (1999), 1496–1501.
Sinnett, D., Krajinovic, M., Labuda, D., Genetic susceptibility to childhood acute lymphoblastic leukemia. Leuk Lymphoma 38:5–6 (2000), 447–462.
Krajinovic, M., Elbared, J., Drouin, S., Bertout, L., Rezgui, A., Ansari, M., et al. Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia. Pharmacogenom J 16 (2016), 530–535.
Marcoux, S., Drouin, S., Laverdiere, C., Alos, N., Andelfinger, G.U., Bertout, L., et al. The PETALE study: late adverse effects and biomarkers in childhood acute lymphoblastic leukemia survivors. Pediatr Blood Cancer, 64(6), 2017 Jun, 10.1002/pbc.26361 Epub 2016 Dec 4.
Vrooman, L.M., Neuberg, D.S., Stevenson, K.E., Asselin, B.L., Athale, U.H., Clavell, L., et al. The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium. Eur J Cancer 47:9 (2011), 1373–1379.
Lambert, M., Delvin, E.E., Levy, E., O'Loughlin, J., Paradis, G., Barnett, T., et al. Prevalence of cardiometabolic risk factors by weight status in a population-based sample of Quebec children and adolescents. Can J Cardiol 24:7 (2008), 575–583.
Statement, P.P., The use of growth charts for assessing and monitoring growth in Canadian infants and children. Can J Diet Pract Res Publ Diet Can Revue canadienne de la pratique et de la recherche en dietetique : une publication des Dietetistes du Canada 65:1 (2004), 22–32.
Alberti, K.G., Zimmet, P., Shaw, J., The metabolic syndrome–a new worldwide definition. Lancet (London, England) 366:9491 (2005), 1059–1062.
Third Report of the National Cholesterol Education Program (NCEP), Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 106:25 (2002), 3143–3421.
Katzmarzyk, P.T., Waist circumference percentiles for Canadian youth 11-18y of age. Eur J Clin Nutr 58:7 (2004), 1011–1015.
World Health Organization, Waist circumference and waist-hip ratio: report of a WHO expert consultation. 2008 http://www.who.int/nutrition/publications/obesity/WHO_report_waistcircumference_and_waisthip_ratio/en/.
Tholen, D.W., Anders, K., Kenndy, J.W., Krouwer, J.S., Meier, K., 2nd ed. Evaluation of precision performance of quantitative measurement methods, approved guidelines, vol. 24, 2004, CLSI, 1–39.
Kaufmann, M., Gallagher, J.C., Peacock, M., Schlingmann, K.P., Konrad, M., DeLuca, H.F., et al. Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by LC-MS/MS involving derivatization with DMEQ-TAD. J Clin Endocrinol Metab 99:7 (2014), 2567–2574.
Delvin, E., Boisvert, M., Lecours, M.A., Théorêt, Y., Kaufmann, M., Jones, G., et al. Supporting data for the measurement of serum vitamin D metabolites in childhood acute lymphoblastic leukemia survivors. Data in Brief, 2018.
Institute of Medicine, Dietary reference intakes for calcium and vitamin D., 2011, The National Academies Press, Washington, DC Report No.: 978-0-309-16394-1.
Weiler, H.A., Leslie, W.D., Krahn, J., Steiman, P.W., Metge, C.J., Canadian Aboriginal women have a higher prevalence of vitamin D deficiency than non-Aboriginal women despite similar dietary vitamin D intakes. J Nutr 137:2 (2007), 461–465.
Anderson, L.N., Cotterchio, M., Vieth, R., Knight, J.A., Vitamin D and calcium intakes and breast cancer risk in pre- and postmenopausal women. Am J Clin Nutr 91:6 (2010), 1699–1707.
Zhou, W., Langsetmo, L., Berger, C., Poliquin, S., Kreiger, N., Barr, S.I., et al. Longitudinal changes in calcium and vitamin D intakes and relationship to bone mineral density in a prospective population-based study: the Canadian Multicentre Osteoporosis Study (CaMos). J Musculoskelet Neuronal Interact 13:4 (2013), 470–479.
Mark, S., Gray-Donald, K., Delvin, E.E., O'Loughlin, J., Paradis, G., Levy, E., et al. Low vitamin D status in a representative sample of youth from Quebec, Canada. Clin Chem 54:8 (2008), 1283–1289.
Langlois, K., Greene-Finestone, L., Little, J., Hidiroglou, N., Whiting, S., Vitamin D status of canadians as measured in the 2007 to 2009 Canadian health measures survey. Health Rep 21:1 (2010), 47–55.
Holick, M.F., Binkley, N.C., Bischoff-Ferrari, H.A., Gordon, C.M., Hanley, D.A., Heaney, R.P., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metabol 96:7 (2011), 1911–1930.
Glendenning, P., Inderjeeth, C.A., Screening for vitamin D deficiency: defining vitamin D deficiency, target thresholds of treatment and estimating the benefits of treatment. Pathology 44:2 (2012), 160–165.
Crews, B.O., Moore, J., Dietzen, D.J., Circulating intact parathyroid hormone is suppressed at 25-hydroxyvitamin D concentrations >25 nmol/L in children. J Pediatr Endocrinol Metab 27:7–8 (2014), 657–660.
Souberbielle, J.C., Massart, C., Brailly-Tabard, S., Cormier, C., Cavalier, E., Delanaye, P., et al. Serum PTH reference values established by an automated third-generation assay in vitamin D-replete subjects with normal renal function: consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients. Eur J Endocrinol 174:3 (2016), 315–323.
Ding, C., Parameswaran, V., Blizzard, L., Burgess, J., Jones, G., Not a simple fat-soluble vitamin: changes in serum 25-(OH)D levels are predicted by adiposity and adipocytokines in older adults. J Intern Med 268:5 (2010), 501–510.
Jorde, R., Sneve, M., Emaus, N., Figenschau, Y., Grimnes, G., Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromso study. Eur J Nutr 49:7 (2010), 401–407.
Mai, X.M., Chen, Y., Camargo, C.A. Jr., Langhammer, A., Cross-sectional and prospective cohort study of serum 25-hydroxyvitamin D level and obesity in adults: the HUNT study. Am J Epidemiol 175:10 (2012), 1029–1036.
Hannemann, A., Thuesen, B.H., Friedrich, N., Volzke, H., Steveling, A., Ittermann, T., et al. Adiposity measures and vitamin D concentrations in Northeast Germany and Denmark. Nutr Metabol, 12, 2015, 24.
Michelsen, J., Wallaschofski, H., Friedrich, N., Spielhagen, C., Rettig, R., Ittermann, T., et al. Reference intervals for serum concentrations of three bone turnover markers for men and women. Bone 57:2 (2013), 399–404.
Bayer, M., Reference values of osteocalcin and procollagen type I N-propeptide plasma levels in a healthy Central European population aged 0-18 years. Osteoporos Intl J Establ Res Coop Between Eur Found Osteoporos Natl Osteoporos Found USA 25:2 (2014), 729–736.
Hannemann, A., Wallaschofski, H., Reference intervals for serum concentrations of three bone turnover markers for men and women. Bone, 93, 2016, 216.
Callegari, E.T., Gorelik, A., Garland, S.M., Chiang, C.Y., Wark, J.D., Bone turnover marker reference intervals in young females. Ann Clin Biochem 54:4 (2017 Jul), 438–447, 10.1177/0004563216665123 Epub 2016 Aug 5.
Madar, A.A., Knutsen, K.V., Stene, L.C., Brekke, M., Lagerløv, P., Meyer, H.E., et al. Effect of vitamin D3-supplementation on bone markers (serum P1NP and CTX): a randomized, double blinded, placebo controlled trial among healthy immigrants living in Norway. Bone Reports 2 (2015), 82–88.
Ginty, F., Cavadini, C., Michaud, P.A., Burckhardt, P., Baumgartner, M., Mishra, G.D., et al. Effects of usual nutrient intake and vitamin D status on markers of bone turnover in Swiss adolescents. Eur J Clin Nutr 58:9 (2004), 1257–1265.
Thiering, E., Bruske, I., Kratzsch, J., Hofbauer, L.C., Berdel, D., von Berg, A., et al. Associations between serum 25-hydroxyvitamin D and bone turnover markers in a population based sample of German children. Sci Rep, 5, 2015, 18138.
Tonks, K.T., White, C.P., Center, J.R., Samocha-Bonet, D., Greenfield, J.R., Bone turnover is suppressed in insulin resistance, independent of adiposity. J Clin Endocrinol Metab 102:4 (2017), 1112–1121.